TW200716602A - Novel compounds - Google Patents
Novel compoundsInfo
- Publication number
- TW200716602A TW200716602A TW095112595A TW95112595A TW200716602A TW 200716602 A TW200716602 A TW 200716602A TW 095112595 A TW095112595 A TW 095112595A TW 95112595 A TW95112595 A TW 95112595A TW 200716602 A TW200716602 A TW 200716602A
- Authority
- TW
- Taiwan
- Prior art keywords
- compounds
- novel compounds
- treatment
- disorders
- responsive
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 208000015114 central nervous system disease Diseases 0.000 abstract 2
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 102000027484 GABAA receptors Human genes 0.000 abstract 1
- 108091008681 GABAA receptors Proteins 0.000 abstract 1
- 229940058303 antinematodal benzimidazole derivative Drugs 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 125000003785 benzimidazolyl group Chemical class N1=C(NC2=C1C=CC=C2)* 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
This invention relates to novel benzimidazole derivatives, pharmaceutical compositions containing these compounds, and methods of treatment therewith. The compounds of the invention are useful in the treatment of central nervous system diseases and disorders, which are responsive to modulation of the GABAA receptor complex, and in particular for combating anxiety and related diseases.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200500530 | 2005-04-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200716602A true TW200716602A (en) | 2007-05-01 |
Family
ID=38048147
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW095112595A TW200716602A (en) | 2005-04-13 | 2006-04-10 | Novel compounds |
Country Status (4)
| Country | Link |
|---|---|
| CN (1) | CN101141958A (en) |
| AR (1) | AR053578A1 (en) |
| BR (1) | BRPI0609417A2 (en) |
| TW (1) | TW200716602A (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107445845A (en) * | 2017-08-24 | 2017-12-08 | 重庆沃肯精细化工有限公司 | The method of one kind synthesis Clofazimine key intermediate N (4 chlorphenyl) 1,2 phenylenediamine |
-
2006
- 2006-04-07 BR BRPI0609417-1A patent/BRPI0609417A2/en not_active IP Right Cessation
- 2006-04-07 CN CNA2006800082378A patent/CN101141958A/en active Pending
- 2006-04-10 TW TW095112595A patent/TW200716602A/en unknown
- 2006-04-12 AR ARP060101465A patent/AR053578A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0609417A2 (en) | 2011-10-18 |
| AR053578A1 (en) | 2007-05-09 |
| CN101141958A (en) | 2008-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY149855A (en) | Benzimidazole derivatives and their use for modulating the gaba? receptor complex | |
| JO2645B1 (en) | Compounds | |
| TNSN08373A1 (en) | Azolopyrimidines as inhibitors of cannabinoid 1 activity | |
| NO20093009L (en) | Condensed ring heterocycle kinase modulators | |
| MA32898B1 (en) | POSITIVE ALLOSTERIC MODULATORS OF ARYLMETHYLBENZOQUINAZOLINONE M1 RECEPTOR | |
| PL1979355T3 (en) | Spiro imidazole derivatives as ppar modulators | |
| MX2007011847A (en) | Pyrimidindione derivatives as prokineticin 2 receptor antagonists. | |
| EA200601798A1 (en) | MORPHOLIN SUBSTITUTED CONNECTIONS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | |
| WO2007042544A3 (en) | Imidazole derivatives and their use for modulating the gabaa receptor complex | |
| TW200631583A (en) | Substituted pteridines for the treatment of inflammatory diseases | |
| GB0611907D0 (en) | Compounds | |
| UA96447C2 (en) | Polymorph forms of (2s)-(4e)-n-methyl-5- (3-isopropoxypyridin) yl]-4-penten-2-amine for the treatment of central nervous system disorders | |
| TW200611695A (en) | Pyrrolopyridine derivatives | |
| EA200801302A1 (en) | COMPOSITIONS AND METHODS OF TREATMENT OF CNS DISORDERS | |
| MX2007002393A (en) | Substituted indole compounds and their use as 5-ht6 receptor modulators. | |
| MX2010005704A (en) | Chromane derivatives as trpv3 modulators. | |
| IL189974A0 (en) | Benzimidazole derivatives and their use for modulating the gabaa receptor complex | |
| TW200635597A (en) | Substituted pteridines for the treatment of inflammatory diseases | |
| MX2007012624A (en) | Benzimidazole derivatives and their use for modulating the gabaa receptor complex. | |
| WO2004087690A3 (en) | Benzimidazole derivatives and their use for modulating the gaba-a receptor complex | |
| TW200633711A (en) | Substituted pteridines for the treatment of inflammatory diseases | |
| UA104861C2 (en) | Chromane derivatives as trpv3 modulators | |
| TW200734335A (en) | Compounds | |
| TW200716602A (en) | Novel compounds | |
| ATE386519T1 (en) | BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS GABA A RECEPTOR COMPLEX MODULATORS |